BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18236694)

  • 1. Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents.
    Alisi A; Balsano C
    Nutr Rev; 2007 Dec; 65(12 Pt 1):550-3. PubMed ID: 18236694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin and liver cancer: a review.
    Darvesh AS; Aggarwal BB; Bishayee A
    Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of Hepatocellular Carcinoma Lung Metastases after Guyabano Fruit Extract Consumption.
    Gunasekaran SS; Emmadi R; Landers LA; Gaba RC
    J Diet Suppl; 2016; 13(3):237-44. PubMed ID: 25664807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
    Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatocellular carcinoma activity and mechanism of chemopreventive compounds: ursolic acid derivatives.
    Huang Q; Chen H; Ren Y; Wang Z; Zeng P; Li X; Wang J; Zheng X
    Pharm Biol; 2016 Dec; 54(12):3189-3196. PubMed ID: 27564455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of interferon therapy after curative treatment of hepatocellular carcinoma.
    Kudo M
    Oncology; 2008; 75 Suppl 1():30-41. PubMed ID: 19092270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
    Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
    J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
    Bishayee A; Politis T; Darvesh AS
    Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
    Song MJ
    World J Gastroenterol; 2015 Apr; 21(13):3843-9. PubMed ID: 25852268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.
    Zhu AX
    Cancer; 2008 Jan; 112(2):250-9. PubMed ID: 18041064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma.
    Zhang Y; Huang H; Jin L; Lin S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia.
    Li YL; Zhang NY; Hu X; Chen JL; Rao MJ; Wu LW; Li QY; Zhang B; Yan W; Zhang C
    Biochem Biophys Res Commun; 2018 Apr; 498(3):481-486. PubMed ID: 29505792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma.
    Lin X; Peng Z; Fu X; Liu C; Xu Y; Ji W; Fan J; Chen L; Fang L; Huang Y; Su C
    Oncotarget; 2016 Nov; 7(48):79761-79773. PubMed ID: 27806329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy for hepatocellular carcinoma.
    Thomas MB
    Cancer J; 2008; 14(2):123-7. PubMed ID: 18391618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective controlled analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages.
    Chen Z; Li B; Yue X; Zhu D; Yu C; Wu M; Ling C
    J Altern Complement Med; 2006 Dec; 12(10):941-2. PubMed ID: 17212565
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycopentalone, a novel compound from Glycosmis pentaphylla (Retz.) Correa with potent anti-hepatocellular carcinoma activity.
    Sreejith PS; Asha VV
    J Ethnopharmacol; 2015 Aug; 172():38-43. PubMed ID: 26068427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway.
    Shu G; Mi X; Cai J; Zhang X; Yin W; Yang X; Li Y; Chen L; Deng X
    Toxicol Lett; 2013 Oct; 222(2):91-101. PubMed ID: 23933019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.